These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1169 related articles for article (PubMed ID: 21512140)

  • 41. Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?
    Hung MH; Wang XW
    Cancer Res; 2023 Nov; 83(21):3498-3500. PubMed ID: 37747420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
    Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
    Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling.
    Khan H; Ni Z; Feng H; Xing Y; Wu X; Huang D; Chen L; Niu Y; Shi G
    Phytomedicine; 2021 Oct; 91():153706. PubMed ID: 34517264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D; Ma X; Sun W; Cui P; Lu Z
    Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
    Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
    J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma.
    Song J; Xie C; Jiang L; Wu G; Zhu J; Zhang S; Tang M; Song L; Li J
    Theranostics; 2018; 8(13):3571-3583. PubMed ID: 30026867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EZH2 Impairs Human Dental Pulp Cell Mineralization via the Wnt/β-Catenin Pathway.
    Li B; Yu F; Wu F; Hui T; A P; Liao X; Yin B; Wang C; Ye L
    J Dent Res; 2018 May; 97(5):571-579. PubMed ID: 29294297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
    Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
    Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
    Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L
    Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focal Adhesion Kinase (FAK) Over-Expression and Prognostic Implication in Pediatric Hepatocellular Carcinoma.
    Francalanci P; Giovannoni I; De Stefanis C; Romito I; Grimaldi C; Castellano A; D'Oria V; Alaggio R; Alisi A
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
    Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
    Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
    Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
    Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
    Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
    Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
    Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
    Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
    Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
    Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.